CA Stock MarketDetailed Quotes

MGRO MustGrow Biologics Corp

Watchlist
  • 1.490
  • 0.0000.00%
15min DelayTrading Jan 27 09:30 ET
76.94MMarket Cap0.00P/E (TTM)

MustGrow Biologics Corp Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
279.18K
0
0
72,630.36%4.71M
4.71M
0
0
0
-49.65%6.48K
0
Operating revenue
--279.18K
--0
--0
72,630.36%4.71M
--4.71M
--0
--0
--0
-49.65%6.48K
--0
Cost of revenue
3.74K
0
Gross profit
275.44K
0
Operating expense
4.62%2M
-17.81%1.02M
0.70%1.12M
-3.06%5.52M
18.57%1.24M
-13.44%1.91M
-12.68%1.24M
11.38%1.12M
88.13%5.69M
-3.10%1.05M
Selling and administrative expenses
11.80%1.74M
0.37%642.53K
-3.33%656.04K
-17.91%3.68M
-2.71%810.35K
-15.93%1.55M
-39.22%640.14K
-9.06%678.62K
115.60%4.48M
14.86%832.9K
-Selling and marketing expense
-25.47%85.34K
-21.99%135.46K
4.05%129.24K
-19.84%558.6K
-30.11%146.25K
-25.14%114.51K
12.79%173.64K
-31.25%124.2K
22.69%696.82K
20.53%209.26K
-General and administrative expense
14.77%1.65M
8.70%507.08K
-4.98%526.81K
-17.56%3.12M
6.49%664.1K
-15.10%1.44M
-48.12%466.49K
-1.97%554.42K
150.50%3.79M
13.08%623.64K
Research and development costs
-3.87%93.53K
-46.98%122.39K
-10.40%307.09K
80.11%857.07K
99.89%186.21K
-51.29%97.3K
159.10%230.83K
265.19%342.73K
3.81%475.86K
-48.14%93.15K
Other operating expenses
-34.79%170.78K
-30.94%258.01K
69.42%161.21K
33.89%978.74K
100.56%248.13K
61.69%261.89K
32.01%373.58K
-41.38%95.15K
50.13%731K
-30.74%123.71K
Operating profit
9.79%-1.72M
17.81%-1.02M
-0.70%-1.12M
85.84%-804.99K
430.31%3.47M
13.39%-1.91M
12.45%-1.24M
-11.55%-1.12M
-88.72%-5.69M
3.10%-1.05M
Net non-operating interest income (expenses)
-5.23%46.23K
13.77%56.11K
7.54%75.04K
126.35%211.6K
-22.72%43.72K
25.85%48.78K
49.32K
1,384.17%69.78K
289.07%93.48K
654.86%56.57K
Non-operating interest income
-5.23%46.23K
13.77%56.11K
7.54%75.04K
104.35%211.6K
-22.72%43.72K
25.85%48.78K
--49.32K
1,406.52%69.78K
3,017.01%103.55K
1,603.01%56.57K
Non-operating interest expense
----
----
----
--0
----
----
----
----
-80.92%10.07K
--0
Other net income (expenses)
-200.46%-2.83K
208.85%6.62K
4,758.88%14.77K
-423.82%-83.55K
-845.09%-80.59K
-91.99%2.81K
-6.08K
109.24%304
1,435.46%25.8K
-8.53K
Gain on sale of security
-200.46%-2.83K
208.85%6.62K
4,758.88%14.77K
-423.82%-83.55K
-845.09%-80.59K
-91.99%2.81K
---6.08K
109.24%304
1,435.46%25.8K
---8.53K
Income before tax
9.62%-1.68M
20.07%-960.21K
1.14%-1.03M
87.84%-676.94K
442.48%3.43M
12.80%-1.86M
15.49%-1.2M
-3.64%-1.05M
-81.66%-5.57M
8.56%-1M
Income tax
Earnings from equity interest net of tax
Net income
9.62%-1.68M
20.07%-960.21K
1.14%-1.03M
87.84%-676.94K
442.48%3.43M
12.80%-1.86M
15.49%-1.2M
-3.64%-1.05M
-81.66%-5.57M
8.56%-1M
Net income continuous operations
9.62%-1.68M
20.07%-960.21K
1.14%-1.03M
87.84%-676.94K
442.48%3.43M
12.80%-1.86M
15.49%-1.2M
-3.64%-1.05M
-81.66%-5.57M
8.56%-1M
Noncontrolling interests
Net income attributable to the company
9.62%-1.68M
20.07%-960.21K
1.14%-1.03M
87.84%-676.94K
442.48%3.43M
12.80%-1.86M
15.49%-1.2M
-3.64%-1.05M
-81.66%-5.57M
8.56%-1M
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders
9.62%-1.68M
20.07%-960.21K
1.14%-1.03M
87.84%-676.94K
442.48%3.43M
12.80%-1.86M
15.49%-1.2M
-3.64%-1.05M
-81.66%-5.57M
8.56%-1M
Diluted earnings per share
25.00%-0.03
0.00%-0.02
0.00%-0.02
90.91%-0.01
450.00%0.07
0.00%-0.04
33.33%-0.02
0.00%-0.02
-57.14%-0.11
0.00%-0.02
Basic earnings per share
25.00%-0.03
0.00%-0.02
0.00%-0.02
90.91%-0.01
450.00%0.07
0.00%-0.04
33.33%-0.02
0.00%-0.02
-57.14%-0.11
0.00%-0.02
Dividend per share
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
--
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue 279.18K0072,630.36%4.71M4.71M000-49.65%6.48K0
Operating revenue --279.18K--0--072,630.36%4.71M--4.71M--0--0--0-49.65%6.48K--0
Cost of revenue 3.74K0
Gross profit 275.44K0
Operating expense 4.62%2M-17.81%1.02M0.70%1.12M-3.06%5.52M18.57%1.24M-13.44%1.91M-12.68%1.24M11.38%1.12M88.13%5.69M-3.10%1.05M
Selling and administrative expenses 11.80%1.74M0.37%642.53K-3.33%656.04K-17.91%3.68M-2.71%810.35K-15.93%1.55M-39.22%640.14K-9.06%678.62K115.60%4.48M14.86%832.9K
-Selling and marketing expense -25.47%85.34K-21.99%135.46K4.05%129.24K-19.84%558.6K-30.11%146.25K-25.14%114.51K12.79%173.64K-31.25%124.2K22.69%696.82K20.53%209.26K
-General and administrative expense 14.77%1.65M8.70%507.08K-4.98%526.81K-17.56%3.12M6.49%664.1K-15.10%1.44M-48.12%466.49K-1.97%554.42K150.50%3.79M13.08%623.64K
Research and development costs -3.87%93.53K-46.98%122.39K-10.40%307.09K80.11%857.07K99.89%186.21K-51.29%97.3K159.10%230.83K265.19%342.73K3.81%475.86K-48.14%93.15K
Other operating expenses -34.79%170.78K-30.94%258.01K69.42%161.21K33.89%978.74K100.56%248.13K61.69%261.89K32.01%373.58K-41.38%95.15K50.13%731K-30.74%123.71K
Operating profit 9.79%-1.72M17.81%-1.02M-0.70%-1.12M85.84%-804.99K430.31%3.47M13.39%-1.91M12.45%-1.24M-11.55%-1.12M-88.72%-5.69M3.10%-1.05M
Net non-operating interest income (expenses) -5.23%46.23K13.77%56.11K7.54%75.04K126.35%211.6K-22.72%43.72K25.85%48.78K49.32K1,384.17%69.78K289.07%93.48K654.86%56.57K
Non-operating interest income -5.23%46.23K13.77%56.11K7.54%75.04K104.35%211.6K-22.72%43.72K25.85%48.78K--49.32K1,406.52%69.78K3,017.01%103.55K1,603.01%56.57K
Non-operating interest expense --------------0-----------------80.92%10.07K--0
Other net income (expenses) -200.46%-2.83K208.85%6.62K4,758.88%14.77K-423.82%-83.55K-845.09%-80.59K-91.99%2.81K-6.08K109.24%3041,435.46%25.8K-8.53K
Gain on sale of security -200.46%-2.83K208.85%6.62K4,758.88%14.77K-423.82%-83.55K-845.09%-80.59K-91.99%2.81K---6.08K109.24%3041,435.46%25.8K---8.53K
Income before tax 9.62%-1.68M20.07%-960.21K1.14%-1.03M87.84%-676.94K442.48%3.43M12.80%-1.86M15.49%-1.2M-3.64%-1.05M-81.66%-5.57M8.56%-1M
Income tax
Earnings from equity interest net of tax
Net income 9.62%-1.68M20.07%-960.21K1.14%-1.03M87.84%-676.94K442.48%3.43M12.80%-1.86M15.49%-1.2M-3.64%-1.05M-81.66%-5.57M8.56%-1M
Net income continuous operations 9.62%-1.68M20.07%-960.21K1.14%-1.03M87.84%-676.94K442.48%3.43M12.80%-1.86M15.49%-1.2M-3.64%-1.05M-81.66%-5.57M8.56%-1M
Noncontrolling interests
Net income attributable to the company 9.62%-1.68M20.07%-960.21K1.14%-1.03M87.84%-676.94K442.48%3.43M12.80%-1.86M15.49%-1.2M-3.64%-1.05M-81.66%-5.57M8.56%-1M
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders 9.62%-1.68M20.07%-960.21K1.14%-1.03M87.84%-676.94K442.48%3.43M12.80%-1.86M15.49%-1.2M-3.64%-1.05M-81.66%-5.57M8.56%-1M
Diluted earnings per share 25.00%-0.030.00%-0.020.00%-0.0290.91%-0.01450.00%0.070.00%-0.0433.33%-0.020.00%-0.02-57.14%-0.110.00%-0.02
Basic earnings per share 25.00%-0.030.00%-0.020.00%-0.0290.91%-0.01450.00%0.070.00%-0.0433.33%-0.020.00%-0.02-57.14%-0.110.00%-0.02
Dividend per share
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion------------

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Trending Stocks
Big Five Big Five

The "Big Five" refers to Canada's five largest banks—Royal Bank of Canada, Toronto-Dominion Bank, Bank of Nova Scotia, Bank of Montreal, and Canadian Imperial Bank of Commerce—which dominate and significantly influence the country's financial sector. The "Big Five" refers to Canada's five largest banks—Royal Bank of Canada, Toronto-Dominion Bank, Bank of Nova Scotia, Bank of Montreal, and Canadian Imperial Bank of Commerce—which dominate and significantly influence the country's financial sector.